These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28445856)

  • 1. Procyanidin, a kind of biological flavonoid, induces protective anti-tumor immunity and protects mice from lethal B16F10 challenge.
    Zhang L; Wang S; Liu Z; Zhang L; Wang S; Wang B
    Int Immunopharmacol; 2017 Jun; 47():251-258. PubMed ID: 28445856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective tumor immunity to melanoma mediated by B16F10 cancer stem cell vaccine.
    Zhao F; Zhang R; Wang J; Wu D; Pan M; Li M; Guo M; Dou J
    Int Immunopharmacol; 2017 Nov; 52():238-244. PubMed ID: 28950176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A DNA vaccine targeting p42.3 induces protective antitumor immunity via eliciting cytotoxic CD8+T lymphocytes in a murine melanoma model.
    Liu H; Geng S; Feng C; Xie X; Wu B; Chen X; Zou Q; Wang S; Cui J; Xing R; Li W; Lu Y; Wang B
    Hum Vaccin Immunother; 2013 Oct; 9(10):2196-202. PubMed ID: 24051432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent systemic antitumor immunity induced by vaccination with chemotactic-prostate tumor associated antigen gene-modified tumor cell and blockade of B7-H1.
    Li N; Qin H; Li X; Zhou C; Wang D; Ma W; Lin C; Zhang Y; Wang S; Zhang S
    J Clin Immunol; 2007 Jan; 27(1):117-30. PubMed ID: 17180470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous tumor vaccine modified with recombinant new castle disease virus expressing IL-7 promotes antitumor immune response.
    Zhao L; Mei Y; Sun Q; Guo L; Wu Y; Yu X; Hu B; Liu X; Liu H
    J Immunol; 2014 Jul; 193(2):735-45. PubMed ID: 24943214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hesperetin as an adjuvant augments protective anti-tumour immunity responses in B16F10 melanoma by stimulating cytotoxic CD8
    Jiang S; Wang S; Zhang L; Tian L; Li L; Liu Z; Dong Q; Lv X; Mu H; Zhang Q; Wang B
    Scand J Immunol; 2020 Apr; 91(4):e12867. PubMed ID: 31975405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCA587 Protein Vaccine Induces Specific Antitumor Immunity Mediated by CD4
    Yang W; Zhang W; Wang X; Tan L; Li H; Wu J; Wu Q; Sun W; Chen J; Yin Y
    Anticancer Agents Med Chem; 2021; 21(6):738-746. PubMed ID: 32723258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8(+) T cell response to adenovirus vaccination and subsequent suppression of tumor growth: modeling, simulation and analysis.
    Wang Q; Klinke DJ; Wang Z
    BMC Syst Biol; 2015 Jun; 9():27. PubMed ID: 26048402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine.
    Karan D; Krieg AM; Lubaroff DM
    Int J Cancer; 2007 Oct; 121(7):1520-8. PubMed ID: 17565748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.
    Fotin-Mleczek M; Duchardt KM; Lorenz C; Pfeiffer R; Ojkić-Zrna S; Probst J; Kallen KJ
    J Immunother; 2011 Jan; 34(1):1-15. PubMed ID: 21150709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated antigen/IL-21-transduced dendritic cell vaccines enhance immunity and inhibit immunosuppressive cells in metastatic melanoma.
    Aravindaram K; Wang PH; Yin SY; Yang NS
    Gene Ther; 2014 May; 21(5):457-67. PubMed ID: 24572790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
    Baghban Rahimi S; Mohebbi A; Vakilzadeh G; Biglari P; Razeghi Jahromi S; Mohebi SR; Shirian S; Gorji A; Ghaemi A
    Arch Virol; 2018 Mar; 163(3):587-597. PubMed ID: 29149434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Listeria-derived ActA is an effective adjuvant for primary and metastatic tumor immunotherapy.
    Wood LM; Pan ZK; Shahabi V; Paterson Y
    Cancer Immunol Immunother; 2010 Jul; 59(7):1049-1058. PubMed ID: 20213121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killed Propionibacterium acnes enhances immunogenicity and tumor growth control of a dendritic-tumor cell hybrid vaccine in a murine melanoma model.
    Ishimura ME; Teixeira D; Silveira GDP; Gambero M; Gama GAC; Pimenta BSO; Rodrigues EG; Longo-Maugéri IM
    PLoS One; 2018; 13(10):e0205148. PubMed ID: 30300366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan gel vaccine protects against tumour growth in an intracaecal mouse model of cancer by modulating systemic immune responses.
    Highton AJ; Girardin A; Bell GM; Hook SM; Kemp RA
    BMC Immunol; 2016 Oct; 17(1):39. PubMed ID: 27756214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
    Moeini S; Saeidi M; Fotouhi F; Mondanizadeh M; Shirian S; Mohebi A; Gorji A; Ghaemi A
    Arch Virol; 2017 Feb; 162(2):333-346. PubMed ID: 27699512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Listeria monocytogenes activated dendritic cell based vaccine for prevention of experimental tumor in mice.
    Khamisabadi M; Arab S; Motamedi M; Khansari N; Moazzeni SM; Gheflati Z; Hadjati J
    Iran J Immunol; 2008 Mar; 5(1):36-44. PubMed ID: 18319523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly (I:C)-DOTAP cationic nanoliposome containing multi-epitope HER2-derived peptide promotes vaccine-elicited anti-tumor immunity in a murine model.
    Alipour Talesh G; Ebrahimi Z; Badiee A; Mansourian M; Attar H; Arabi L; Jalali SA; Jaafari MR
    Immunol Lett; 2016 Aug; 176():57-64. PubMed ID: 27260485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.